LAUSR

5. Osiya S, Binesh F, Ferdosian F, Shakiba M. Hematologic manifestations in a child with HIV; a case report. Iran J Pediatr Hematol Oncol 2012; 2:178–181. 6. Soentjens P, Ostyn B, Van Outryve S, Ysebaert D, Vekemans M, Colebunders R. Portal vein thrombosis in a patient with HIV treated with a protease inhibitor-containing regimen. Acta Clin Belg 2006; 61:24–29. 7. Ramanampamonjy RM, Ramarozatovo LS, Bonnet F, et al. [Portal vein thrombosis in HIV-infected patients: report of four cases]. Rev Med Interne 2005; 26:545–548. 8. Hollande C, Mallet V, Darbeda S, et al. Impact of obliterative portal venopathy associated with human immunodeficiency virus. Medicine (Baltimore) 2016; 95: e3081. 9. Pontrelli G, Martino AM, Tchidjou HK, et al. HIV is associated with thrombophilia and high D-dimer in children and adolescents. AIDS 2010; 24:1145–1151. 10. Funderburg NT. Markers of coagulation and inflammation often remain elevated in ART-treated HIV-infected patients. Curr Opin HIV AIDS 2014; 9:80–86. 11. Cerrato E, Calcagno A, D’Ascenzo F, et al. Cardiovascular disease in HIV patients: from bench to bedside and backwards. Open Heart 2015; 2:e000174. 12. Govender I, Mabuza HL, Ogunbanjo GA. The characteristics of HIV and AIDS patients with deep vein thrombosis at Dr George Mukhari Academic Hospital. Afr J Prim Healthcare Fam Med 2015; 7:doi: 10.4102/phcfm.v7i1.690. 13. Sule AA, Pandit N, Handa P, et al. A case series of HIVseropositive patients and hypercoagulable state-is it difficult to treat even with therapeutic anticoagulation? Int J Angiol 2013; 22:105–108.